Novo Nordisk A/S (NVO) Financials

NVO Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 90.8 billion 57.1 billion
March 31, 2026 85.8 billion 54.6 billion
Dec. 31, 2025 85.3 billion 54.8 billion
Sept. 30, 2025 80.5 billion 53.8 billion

NVO Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 6.5 billion ?
March 31, 2026 1.8 billion ?
Dec. 31, 2025 -5.7 billion ?
Sept. 30, 2025 4.8 billion ?

NVO Net Income
Graph available only for paid members. Upgrade to see it.
DateNet Income
June 30, 2026 3.2 billion
March 31, 2026 7.4 billion
Dec. 31, 2025 4.2 billion
Sept. 30, 2025 3.1 billion

NVO Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 6.9 billion 18.6 billion -
March 31, 2026 3.3 billion 18.3 billion -
Dec. 31, 2025 4.2 billion 17.3 billion 1.3 billion
Sept. 30, 2025 5.1 billion 14.0 billion -

NVO Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 677.3 million
March 31, 2026 682.4 million
Dec. 31, 2025 699.1 million
Sept. 30, 2025 699.1 million

NVO Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 2.0 billion 2.7 billion 2.5 billion 2.3 billion
March 31, 2026 1.8 billion 1.6 billion 2.0 billion 1.9 billion
Dec. 31, 2025 6.9 billion 2.3 billion 2.7 billion 2.5 billion
Sept. 30, 2025 2.4 billion 2.4 billion 2.8 billion 2.5 billion

NVO Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 12.0 billion 2.6 billion
March 31, 2026 14.9 billion 2.1 billion
Dec. 31, 2025 12.4 billion 2.4 billion
Sept. 30, 2025 11.8 billion 2.8 billion

NVO

Price: $46.93

52 week price:
34.58
64.16

Dividend Yield: 3.80%

5-year range yield:
0.74%
4.93%

Forward Dividend Yield: 2.48%

Payout Ratio: 24.32%

Payout Ratio Range:
0.01%
449.50%

Dividend Per Share: 1.16 USD

Earnings Per Share: 4.09 USD

P/E Ratio: 11.67

Exchange: NYQ

Sector: Healthcare

Industry: Drug Manufacturers - General

Country: Denmark

Volume: 1.1 million

Ebitda: 1.9 billion

Market Capitalization: 209.1 billion

Average Dividend Frequency: 2

Years Paying Dividends: 45

DGR3: 29.57%

DGR5: 22.96%

DGR10: 20.32%

DGR20: 22.69%

Links: